Singapore markets closed

ARCA biopharma, Inc. (ABIO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.2940+0.0440 (+1.36%)
As of 10:14AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close3.2500
Open3.3500
Bid3.2300 x 200
Ask3.3400 x 200
Day's range3.2850 - 3.3500
52-week range1.5600 - 3.8800
Volume23,904
Avg. volume1,476,378
Market cap47.786M
Beta (5Y monthly)1.21
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Benzinga

    Small-Cap ARCA Biopharma Stock Soars On Merger Pact: The Details

    ARCA Biopharma Inc (NASDAQ:ABIO) and Oruka Therapeutics have entered into a definitive agreement to combine the companies in an all-stock transaction. Oruka Therapeutics is a privately held biotechnology company developing novel biologics for chronic skin diseases, including plaque psoriasis. The resulting entity will focus on advancing Oruka’s pipeline, including ORKA-001 (an IL-23p19 inhibitor) and ORKA-002 (an IL-17A/F inhibitor). Upon completion of the merger, the combined company plans to o

  • Simply Wall St.

    We're Not Very Worried About ARCA biopharma's (NASDAQ:ABIO) Cash Burn Rate

    Just because a business does not make any money, does not mean that the stock will go down. For example, although...